Search results
Results from the WOW.Com Content Network
Modified-release dosage is a mechanism that (in contrast to immediate-release dosage) delivers a drug with a delay after its administration (delayed-release dosage) or for a prolonged period of time (extended-release [ER, XR, XL] dosage) or to a specific target in the body (targeted-release dosage). [1]
Patients in response categories 4-9 should be considered as failing to respond to treatment (disease progression). Thus, an incorrect treatment schedule or drug administration does not result in exclusion from the analysis of the response rate. Precise definitions for categories 4-9 will be protocol specific.
Release (Liberation) is the first step in the process by which medication enters the body and liberates the active ingredient that has been administered. The pharmaceutical drug must separate from the vehicle or the excipient that it was mixed with during manufacture. Some authors split the process of liberation into three steps: disintegration ...
The drug formulation (immediate release, excipients used, manufacturing methods, modified release – delayed release, extended release, sustained release, etc.) Whether the formulation is administered in a fed or fasted state; Gastric emptying rate; Circadian differences; Interactions with other drugs/foods:
A disease-modifying treatment, disease-modifying drug, or disease-modifying therapy is a treatment that delays, slows or reverses the progression of a disease by targeting its underlying cause. [1] They are distinguished from symptomatic treatments that treat the symptoms of a disease but do not address its underlying cause. [2]
myeloproliferative disease(s) MPGN: membranoproliferative glomerulonephritis: MPO: myeloperoxidase MPT: multi-professional team MPV: mean platelet volume: MR: medical representative mental retardation mitral regurgitation modified release (compare time release technology (medicine)) menstrual regulation (unsafe abortion) MRA: magnetic resonance ...
The drugs would have been worth up to NZ$3.8 million, or $2.2 million USD, the customs agency said in a news release. The duffel bag and disguised drugs. / Credit: New Zealand Customs Service.
Extended-release (or slow-release) formulations of morphine are those whose effect last substantially longer than bare morphine, availing for, e.g., one administration per day. Conversion between extended-release and immediate-release (or "regular") morphine is easier than conversion to or from an equianalgesic dose of another opioid with ...